{
    "title": "111_hr1230",
    "content": "SECTION 1. SHORT TITLE.\n\n    This Act may be cited as the ``Acquired Bone Marrow Failure Disease \nResearch and Treatment Act of 2010''.\n\nSEC. 2. ACQUIRED BONE MARROW FAILURE DISEASE RESEARCH.\n\n    Part B of title III of the Public Health Service Act (42 U.S.C. 243 \net seq.) is amended by inserting after section 317T the following:\n\n``SEC. 317U. ACQUIRED BONE MARROW FAILURE DISEASE RESEARCH.\n\n    ``(a) In General.--The Secretary may conduct research on acquired \nbone marrow failure diseases. Such research may address factors \nincluding--\n            ``(1) trends in the characteristics of individuals who are \n        diagnosed with acquired bone marrow failure diseases, including \n        age, race and ethnicity, general geographic location, sex, \n        family history, and any other characteristics determined \n        appropriate by the Secretary;\n            ``(2) the genetic and environmental factors, including \n        exposure to toxins, that may be associated with developing \n        acquired bone marrow failure diseases;\n            ``(3) approaches to treating acquired bone marrow failure \n        diseases;\n            ``(4) outcomes for individuals treated for acquired bone \n        marrow failure diseases, including outcomes for recipients of \n        stem cell therapeutic products; and\n            ``(5) any other factors pertaining to acquired bone marrow \n        failure diseases determined appropriate by the Secretary.\n    ``(b) Collaboration With the Radiation Injury Treatment Network.--\nIn carrying out subsection (a), the Secretary may collaborate with the \nRadiation Injury Treatment Network of the C.W. Bill Young Cell \nTransplantation Program established pursuant to section 379 to--\n            ``(1) augment data for the studies under such subsection;\n            ``(2) access technical assistance that may be provided by \n        the Radiation Injury Treatment Network; or\n            ``(3) perform joint research projects.\n    ``(c) Definition.--In this section, the term `acquired bone marrow \nfailure disease' means--\n            ``(1) myelodysplastic syndromes (MDS);\n            ``(2) aplastic anemia;\n            ``(3) paroxysmal nocturnal hemoglobinuria (PNH);\n            ``(4) pure red cell aplasia;\n            ``(5) acute myeloid leukemia that has progressed from \n        myelodysplastic syndromes;\n            ``(6) large granular lymphocytic leukemia; or\n            ``(7) any other bone marrow failure disease specified by \n        the Secretary, to the extent such disease is acquired and not \n        inherited, as determined by the Secretary.''.\n\nSEC. 3. MINORITY-FOCUSED PROGRAMS ON ACQUIRED BONE MARROW FAILURE \n              DISEASES.\n\n    Title XVII of the Public Health Service Act (42 U.S.C. 300u et \nseq.) is amended by inserting after section 1707A the following:\n\n``SEC. 1707B. MINORITY-FOCUSED PROGRAMS ON ACQUIRED BONE MARROW FAILURE \n              DISEASES.\n\n    ``(a) Information and Referral Services.--\n            ``(1) In general.--The Secretary may establish and \n        coordinate outreach and informational programs targeted to \n        minority populations, including Hispanic, Asian-American, \n        Native Hawaiian, and Pacific Islander populations, that are \n        affected by acquired bone marrow failure diseases.\n            ``(2) Program activities.--Programs under subsection (a) \n        may carry out activities that include--\n                    ``(A) making information about treatment options \n                and clinical trials for acquired bone marrow failure \n                diseases publicly available; and\n                    ``(B) providing referral services for treatment \n                options and clinical trials.\n    ``(b) Definition.--In this section, the term `acquired bone marrow \nfailure disease' has the meaning given such term in section 317U(c).''.\n\nSEC. 4. BEST PRACTICES FOR DIAGNOSIS OF AND CARE FOR INDIVIDUALS WITH \n              ACQUIRED BONE MARROW FAILURE DISEASES.\n\n    Part B of title III of the Public Health Service Act (42 U.S.C. 243 \net seq.), as amended by section 2, is further amended by inserting \nafter section 317U the following:\n\n``SEC. 317V. BEST PRACTICES FOR DIAGNOSIS OF AND CARE FOR INDIVIDUALS \n              WITH ACQUIRED BONE MARROW FAILURE DISEASES.\n\n    ``(a) Grants.--The Secretary, acting through the Director of the \nAgency for Healthcare Research and Quality, may award grants to \nresearchers to study best practices with respect to diagnosing acquired \nbone marrow failure diseases and providing care to individuals with \nsuch diseases.\n    ``(b) Definition.--In this section, the term `acquired bone marrow \nfailure disease' has the meaning given such term in section 317U(c).''.\n\n            Passed the House of Representatives September 30 \n      (legislative day September 29), 2010.\n\n            Attest:\n\n                                            LORRAINE C. MILLER,\n\n                                                                 Clerk."
}